# Pathogenesis of Hematologic Malignancies

> **NCT01728402** · — · ENROLLING_BY_INVITATION · sponsor: **OHSU Knight Cancer Institute** · enrollment: 5000 (estimated)

## Conditions studied

- Acute Leukemia
- Lymphoproliferative Disorders
- Myeloproliferative Disorders
- Myelodysplastic Syndromes

## Interventions

- **PROCEDURE:** blood draw, bone marrow procedure, or tissue biopsy

## Key facts

- **NCT ID:** NCT01728402
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2008-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01728402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01728402, "Pathogenesis of Hematologic Malignancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01728402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*